The NSW Government is investing $9 million over the next five years on clinical trials that will explore the use of cannabis and cannabis products in providing relief from a range of debilitating or terminal illnesses.
Clinical trials in three areas were announced in December 2014 to explore the use of cannabis and cannabis products in providing relief for:
- Children with severe, drug-resistant epilepsy, through a partnership with the Sydney Children’s Hospitals Network
- Adult palliative care patients, focusing on quality of life, particularly appetite and appetite-related symptoms
- Adults with chemotherapy-induced nausea and vomiting, where standard treatment is ineffective.
Children with severe, drug-resistant epilepsy, through a partnership with the Sydney Children’s Hospitals Network.
Adult palliative care patients, focusing on quality of life, particularly appetite and appetite-related symptoms
Adults with chemotherapy-induced nausea and vomiting, where standard treatment is ineffective.
Frequently asked questions
- How can I become a participant in these clinical trials?
Once the scope of each trial is finalised, further information on eligibility will be made available.
- What type of cannabis products will be used in these clinical trials?
Cannabis is a complex plant that contains a range of different chemicals, called cannabinoids. The concentration of cannabinoids varies from strain to strain of plant, and depends on the type of growing and harvesting conditions.
To ensure the clinical trials produce reliable results, they must use a standardised product that meets the strict standards of production, as well as the Therapeutic Goods Administration’s Clinical Trials standards. Suitable products will be assessed as part of the application process to conduct the clinical trials.
- Progress on establishing the clinical trials
Details of a clinical trial for adults with terminal illness, for adults suffering nausea and vomiting whilst undergoing chemotherapy and a clinical trial for children with severe, drug-resistant epilepsy have now been announced.
- For more information
- call the Cannabis Trials Help Line on 1800 217 257
- write to Cannabis Trials, NSW Ministry of Health, Locked Mail Bag 961, North Sydney, NSW 2059
- email the NSW Ministry of Health on email@example.com